• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Aurobindo > December 08, 2010

      Aurobindo Pharma Gets USFDA Approval For Duloxetine Hydrochloride Capsules

      Posted Atstockmarketsreview.com

      (RTTNews) - The Hyderabad-based Aurobindo Pharma Ltd. announced that the company had received tentative approval from the US FDA to manufacture and market Duloxetine Hydrochloride Delayed-Release capsules 20mg (base), 30mg (base) and 60mg (base).

      Duloxetine Hydrochloride Delay-Release capsules are the generic equivalent of Eli Lilly and Company's Cymbalta Delayed-Release capsules 20mg (base), 30mg (base) and 60mg (base).

      Duloxetine Hydrochloride Delayed-Release capsules are indicated for the treatment of major depressive disorder and fall under the Neurological therapeutic category.

      As per IMS data, the product has a market size of around $2.9 billion for the twelve months ended June 2010.

      At the BSE, Aurobindo Pharma shares are being traded at Rs.1,301, up by 0.143% from the previous close.

      December 08, 2010


       

      Share this Article!

    Back to top^